ATE367450T1 - Verfahren zur herstellung sequenzspezifischer proteasen durch gezielte evolution - Google Patents

Verfahren zur herstellung sequenzspezifischer proteasen durch gezielte evolution

Info

Publication number
ATE367450T1
ATE367450T1 AT03727460T AT03727460T ATE367450T1 AT E367450 T1 ATE367450 T1 AT E367450T1 AT 03727460 T AT03727460 T AT 03727460T AT 03727460 T AT03727460 T AT 03727460T AT E367450 T1 ATE367450 T1 AT E367450T1
Authority
AT
Austria
Prior art keywords
specific proteases
proteases
producing sequence
targeted evolution
sequence
Prior art date
Application number
AT03727460T
Other languages
English (en)
Inventor
Andre Koltermann
Ulrich Kettling
Ulrich Haupts
Jan Tebbe
Peter Scholz
Jens Pilling
Susanne Werner
Markus Rarbach
Original Assignee
Direvo Biotech Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Direvo Biotech Ag filed Critical Direvo Biotech Ag
Application granted granted Critical
Publication of ATE367450T1 publication Critical patent/ATE367450T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/58Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi
    • C12N9/60Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi from yeast
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1058Directional evolution of libraries, e.g. evolution of libraries is achieved by mutagenesis and screening or selection of mixed population of organisms

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Ecology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT03727460T 2002-05-10 2003-05-09 Verfahren zur herstellung sequenzspezifischer proteasen durch gezielte evolution ATE367450T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02010576A EP1361284A1 (de) 2002-05-10 2002-05-10 Verfahren zur Herstellung von sequenzspezifischen Proteasen durch zielgerichtete Evolution und deren Verwendung

Publications (1)

Publication Number Publication Date
ATE367450T1 true ATE367450T1 (de) 2007-08-15

Family

ID=29225644

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03727460T ATE367450T1 (de) 2002-05-10 2003-05-09 Verfahren zur herstellung sequenzspezifischer proteasen durch gezielte evolution

Country Status (9)

Country Link
EP (2) EP1361284A1 (de)
JP (1) JP4448772B2 (de)
AT (1) ATE367450T1 (de)
AU (2) AU2003233314A1 (de)
CA (1) CA2485452A1 (de)
DE (1) DE60315014T2 (de)
DK (1) DK1504117T3 (de)
ES (1) ES2289288T3 (de)
WO (1) WO2003095670A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7939304B2 (en) 2002-10-02 2011-05-10 Catalyst Biosciences, Inc. Mutant MT-SP1 proteases with altered substrate specificity or activity
WO2004113521A1 (en) 2003-06-18 2004-12-29 Direvo Biotech Ag New biological entities and the use thereof
WO2005087947A2 (en) * 2004-03-09 2005-09-22 Meyer Pharmaceuticals Llc Bioengineered proteolytic enzymes with enhanced specificity for cytokine receptors
JP5629423B2 (ja) 2004-04-12 2014-11-19 カタリスト バイオサイエンシーズ, インコーポレイテッド 野生型及び変異型mt−sp1による、vegf及びvegf受容体の切断
WO2006067198A2 (en) * 2004-12-22 2006-06-29 Direvo Biotech Ag Targeted use of engineered enzymes
WO2007047995A2 (en) 2005-10-21 2007-04-26 Catalyst Biosciences, Inc. Modified proteases that inhibit complement activation
KR20140072201A (ko) 2006-07-05 2014-06-12 카탈리스트 바이오사이언시즈, 인코포레이티드 프로테아제 스크리닝 방법 및 이에 의해 확인된 프로테아제
TWI538916B (zh) 2008-04-11 2016-06-21 介控生化科技公司 經修飾的因子vii多肽和其用途
WO2012128260A1 (ja) 2011-03-24 2012-09-27 旭硝子株式会社 シゾサッカロミセス属酵母の形質転換体、該形質転換体の製造方法、β-グルコシダーゼの製造方法、およびセルロースの分解方法
WO2020073553A1 (zh) * 2018-10-10 2020-04-16 上饶市康可得生物科技有限公司 筛选蛋白酶变体的方法以及获得的蛋白酶变体
CN111019925B (zh) * 2018-10-10 2022-08-23 上饶市康可得生物科技有限公司 筛选蛋白酶变体的方法以及获得的蛋白酶变体
WO2021030787A1 (en) 2019-08-15 2021-02-18 Catalyst Biosciences, Inc. Modified factor vii polypeptides for subcutaneous administration and on-demand treatment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9718591D0 (en) * 1997-09-03 1997-11-05 Zeneca Ltd Methods
WO2001094332A1 (en) * 2000-06-02 2001-12-13 Regents Of The University Of California Profiling of protease specificity using combinatorial fluorogenic substrate libraries

Also Published As

Publication number Publication date
AU2003233314A1 (en) 2003-11-11
WO2003095670A2 (en) 2003-11-20
WO2003095670A3 (en) 2004-04-01
AU2009200749A1 (en) 2009-03-19
JP2005525123A (ja) 2005-08-25
AU2009200749B2 (en) 2011-08-25
EP1361284A1 (de) 2003-11-12
DK1504117T3 (da) 2007-11-12
CA2485452A1 (en) 2003-11-20
EP1504117A2 (de) 2005-02-09
DE60315014D1 (de) 2007-08-30
JP4448772B2 (ja) 2010-04-14
DE60315014T2 (de) 2008-04-10
ES2289288T3 (es) 2008-02-01
EP1504117B1 (de) 2007-07-18

Similar Documents

Publication Publication Date Title
DE60315014D1 (de) Verfahren zur herstellung sequenzspezifischer proteasen durch gezielte evolution
DE60214513D1 (de) Verfahren zur oberflächenmodifizierung
ATE445334T1 (de) Verfahren zur herstellung von konzentratverdickungszusammensetzungen
ATE488533T1 (de) Verfahren zur herstellung von modifiziertem polymer, vorrichtung zur herstellung von modifiziertem polymer und modifiziertes polymer
DE50212867D1 (de) Verfahren zur herstellung einer wässrigen acrylamidlösung mit einem biokatalysator
ATE352864T1 (de) Verfahren zur herstellung von nanostrukturierten glühkörpern zur lichterzeugung
EA200400878A1 (ru) Новые эфиры флуоренкарбоновых кислот, способ их получения, а также их применение в качестве лекарственных средств
ATE510024T1 (de) Verfahren zur herstellung eines gepaarten tag aus einer nukleinsäuresequenz sowie verfahren zur verwendung davon
ATE354282T1 (de) Verfahren zur herstellung eines sojaproteinhydrolysates
DE60236014D1 (de) Verfahren zur herstellung von insulinverbindungen
ATE318254T1 (de) Verfahren zur herstellung einer wässrigen alkaliacrylat-lösung
CY1113871T1 (el) Διαδικασια παρασκευης γκαμπαπεντινης
DE10242955B4 (de) Kunststoffaß und Verfahren zur Herstellung des Fasses
ATE392424T1 (de) Carbaminsäureester mit anticholinerger wirksamkeit
ATE503500T1 (de) Verfahren zur keimreduktion von abformmaterialien
DK1765770T3 (da) Fremgangsmåde til fremstilling af gabapentin
ATE335855T1 (de) Bakterien und verfahren zur herstellung von riboflavin durch fermentation
ATE386027T1 (de) Verfahren zur herstellung von valsartan
DE60317413D1 (de) Verfahren zur Herstellung von Perfluorpolyethern mit Acylfluor-Endgruppen durch Reduktion von peroxidischen Perfluoropolyethern
DE602005024679D1 (de) Verfahren zur herstellung von iminostilbenderivaten
ATE361272T1 (de) Verfahren zur herstellung von 3,3- diarylpropylaminen
ATE509899T1 (de) Verfahren zur rückgewinnung von cumol
ATE291569T1 (de) Verfahren zur herstellung von dnda
DE602004023633D1 (de) Verfahren zur herstellung von 2,3,6,7,10,11-hexahydroxytriphenylen
ATE525911T1 (de) Verfahren zur verbesserung der fleischqualität von fisch,proteinhydrolysat und verfahren zur herstellung eines proteinhydrolysats

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1504117

Country of ref document: EP

EEIH Change in the person of patent owner